Copyright Reports & Markets. All rights reserved.

Global Human Vaccines Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Human Vaccines Market Overview

      • 1.1 Product Overview and Scope of Human Vaccines
      • 1.2 Human Vaccines Segment by Type
        • 1.2.1 Global Human Vaccines Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Varicella
        • 1.2.3 Influenza
        • 1.2.4 Polio
        • 1.2.5 Hepatitis A
        • 1.2.6 Rabies
        • 1.2.7 BCG
        • 1.2.8 Hepatitis B
        • 1.2.9 Other
      • 1.3 Human Vaccines Segment by Application
        • 1.3.1 Human Vaccines Consumption Comparison by Application (2014-2025)
        • 1.3.2 Adults
        • 1.3.3 Children
      • 1.4 Global Human Vaccines Market by Region
        • 1.4.1 Global Human Vaccines Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Human Vaccines Market Size
        • 1.5.1 Global Human Vaccines Revenue (2014-2025)
        • 1.5.2 Global Human Vaccines Production (2014-2025)

      2 Global Human Vaccines Market Competition by Manufacturers

      • 2.1 Global Human Vaccines Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Human Vaccines Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Human Vaccines Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Human Vaccines Production Sites, Area Served, Product Types
      • 2.5 Human Vaccines Market Competitive Situation and Trends
        • 2.5.1 Human Vaccines Market Concentration Rate
        • 2.5.2 Human Vaccines Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Human Vaccines Production Market Share by Regions

      • 3.1 Global Human Vaccines Production Market Share by Regions
      • 3.2 Global Human Vaccines Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Human Vaccines Production
        • 3.4.1 North America Human Vaccines Production Growth Rate (2014-2019)
        • 3.4.2 North America Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Human Vaccines Production
        • 3.5.1 Europe Human Vaccines Production Growth Rate (2014-2019)
        • 3.5.2 Europe Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Human Vaccines Production (2014-2019)
        • 3.6.1 China Human Vaccines Production Growth Rate (2014-2019)
        • 3.6.2 China Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Human Vaccines Production (2014-2019)
        • 3.7.1 Japan Human Vaccines Production Growth Rate (2014-2019)
        • 3.7.2 Japan Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Human Vaccines Consumption by Regions

      • 4.1 Global Human Vaccines Consumption by Regions
      • 4.2 North America Human Vaccines Consumption (2014-2019)
      • 4.3 Europe Human Vaccines Consumption (2014-2019)
      • 4.4 China Human Vaccines Consumption (2014-2019)
      • 4.5 Japan Human Vaccines Consumption (2014-2019)

      5 Global Human Vaccines Production, Revenue, Price Trend by Type

      • 5.1 Global Human Vaccines Production Market Share by Type (2014-2019)
      • 5.2 Global Human Vaccines Revenue Market Share by Type (2014-2019)
      • 5.3 Global Human Vaccines Price by Type (2014-2019)
      • 5.4 Global Human Vaccines Production Growth by Type (2014-2019)

      6 Global Human Vaccines Market Analysis by Applications

      • 6.1 Global Human Vaccines Consumption Market Share by Application (2014-2019)
      • 6.2 Global Human Vaccines Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Human Vaccines Business

      • 7.1 CNBG
        • 7.1.1 CNBG Human Vaccines Production Sites and Area Served
        • 7.1.2 Human Vaccines Product Introduction, Application and Specification
        • 7.1.3 CNBG Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Changsheng Life
        • 7.2.1 Changsheng Life Human Vaccines Production Sites and Area Served
        • 7.2.2 Human Vaccines Product Introduction, Application and Specification
        • 7.2.3 Changsheng Life Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Zhifei
        • 7.3.1 Zhifei Human Vaccines Production Sites and Area Served
        • 7.3.2 Human Vaccines Product Introduction, Application and Specification
        • 7.3.3 Zhifei Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 ChengDa Bio
        • 7.4.1 ChengDa Bio Human Vaccines Production Sites and Area Served
        • 7.4.2 Human Vaccines Product Introduction, Application and Specification
        • 7.4.3 ChengDa Bio Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Kangtai
        • 7.5.1 Kangtai Human Vaccines Production Sites and Area Served
        • 7.5.2 Human Vaccines Product Introduction, Application and Specification
        • 7.5.3 Kangtai Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 SINOVAC BIOTECH
        • 7.6.1 SINOVAC BIOTECH Human Vaccines Production Sites and Area Served
        • 7.6.2 Human Vaccines Product Introduction, Application and Specification
        • 7.6.3 SINOVAC BIOTECH Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Hissen
        • 7.7.1 Hissen Human Vaccines Production Sites and Area Served
        • 7.7.2 Human Vaccines Product Introduction, Application and Specification
        • 7.7.3 Hissen Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Walvax Biotechnology
        • 7.8.1 Walvax Biotechnology Human Vaccines Production Sites and Area Served
        • 7.8.2 Human Vaccines Product Introduction, Application and Specification
        • 7.8.3 Walvax Biotechnology Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GSK
        • 7.9.1 GSK Human Vaccines Production Sites and Area Served
        • 7.9.2 Human Vaccines Product Introduction, Application and Specification
        • 7.9.3 GSK Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 SANOFI
        • 7.10.1 SANOFI Human Vaccines Production Sites and Area Served
        • 7.10.2 Human Vaccines Product Introduction, Application and Specification
        • 7.10.3 SANOFI Human Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Rong An
      • 7.12 NuoCheng Bio
      • 7.13 Hualan Bio
      • 7.14 Tiantan biological
      • 7.15 Changchun Baike
      • 7.16 Adimmune
      • 7.17 Zhongyianke Biotech

      8 Human Vaccines Manufacturing Cost Analysis

      • 8.1 Human Vaccines Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Human Vaccines
      • 8.4 Human Vaccines Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Human Vaccines Distributors List
      • 9.3 Human Vaccines Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Human Vaccines Market Forecast

      • 11.1 Global Human Vaccines Production, Revenue Forecast
        • 11.1.1 Global Human Vaccines Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Human Vaccines Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Human Vaccines Price and Trend Forecast (2019-2025)
      • 11.2 Global Human Vaccines Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Human Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Human Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Human Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Human Vaccines Production, Revenue Forecast (2019-2025)
      • 11.3 Global Human Vaccines Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Human Vaccines Consumption Forecast (2019-2025)
        • 11.3.2 Europe Human Vaccines Consumption Forecast (2019-2025)
        • 11.3.3 China Human Vaccines Consumption Forecast (2019-2025)
        • 11.3.4 Japan Human Vaccines Consumption Forecast (2019-2025)
      • 11.4 Global Human Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Human Vaccines Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

        The global Human Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Human Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        CNBG
        Changsheng Life
        Zhifei
        ChengDa Bio
        Kangtai
        SINOVAC BIOTECH
        Hissen
        Walvax Biotechnology
        GSK
        SANOFI
        Rong An
        NuoCheng Bio
        Hualan Bio
        Tiantan biological
        Changchun Baike
        Adimmune
        Zhongyianke Biotech

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Varicella
        Influenza
        Polio
        Hepatitis A
        Rabies
        BCG
        Hepatitis B
        Other

        Segment by Application
        Adults
        Children

        Buy now